{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:56:54Z","timestamp":1787241414519,"version":"build-2736575974"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:p>\n                    Inflammatory myofibroblastic tumor (IMT) is a distinctive fibroblastic and myofibroblastic spindle cell neoplasm with an accompanying inflammatory cell infiltrate and frequent receptor tyrosine kinase activation at the molecular level. The tumor may recur and rarely metastasizes. IMT is rare in the head and neck region, and limited information is available about its clinicopathologic and molecular characteristics in these subsites. Therefore, we analyzed a cohort of head and neck IMTs through a multi-institutional approach. Fourteen cases were included in the provisional cohort, but 1 was excluded after molecular analysis prompted reclassification. Patients in the final cohort included 7 males and 6 females, with a mean age of 26.5 years. Tumors were located in the larynx (n=7), oral cavity (n=3), pharynx (n=2), and mastoid (n=1). Histologically, all tumors showed neoplastic spindle cells in storiform to fascicular patterns with associated chronic inflammation, but the morphologic spectrum was wide, as is characteristic of IMT in other sites. An underlying fusion gene event was identified in 92% (n=11\/12) of cases and an additional case was ALK-positive by IHC but could not be evaluated molecularly.\n                    <jats:italic toggle=\"yes\">ALK<\/jats:italic>\n                    represented the driver in all but 1 case. Rearrangement of\n                    <jats:italic toggle=\"yes\">ALK<\/jats:italic>\n                    , fused with the\n                    <jats:italic toggle=\"yes\">TIMP3<\/jats:italic>\n                    gene (n=6) was most commonly detected, followed by 1 case each of the following fusion gene partnerships:\n                    <jats:italic toggle=\"yes\">TPM3<\/jats:italic>\n                    -\n                    <jats:italic toggle=\"yes\">ALK<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">KIF5B<\/jats:italic>\n                    -\n                    <jats:italic toggle=\"yes\">ALK<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">CARS<\/jats:italic>\n                    -\n                    <jats:italic toggle=\"yes\">ALK<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">THBS1<\/jats:italic>\n                    -\n                    <jats:italic toggle=\"yes\">ALK<\/jats:italic>\n                    , and a novel alteration,\n                    <jats:italic toggle=\"yes\">SLC12A2<\/jats:italic>\n                    -\n                    <jats:italic toggle=\"yes\">ROS1<\/jats:italic>\n                    . The excluded case was reclassified as spindle cell rhabdomyosarcoma after detection of a\n                    <jats:italic toggle=\"yes\">FUS<\/jats:italic>\n                    -\n                    <jats:italic toggle=\"yes\">TFCP2<\/jats:italic>\n                    rearrangement and retrospective immunohistochemical confirmation of rhabdomyoblastic differentiation, illustrating an important diagnostic pitfall. Two IMT patients received targeted therapy with crizotinib, with a demonstrated radiographic response. One tumor recurred but none metastasized. These results add to the growing body of evidence that kinase fusions can be identified in the majority of IMTs and that molecular analysis can lead to increased diagnostic accuracy and broadened therapeutic options for patients.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000001735","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T16:22:45Z","timestamp":1621441365000},"page":"1707-1719","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":44,"title":["Clinicopathologic and Genomic Characterization of Inflammatory Myofibroblastic Tumors of the Head and Neck"],"prefix":"10.1097","volume":"45","author":[{"given":"Darcy A.","family":"Kerr","sequence":"first","affiliation":[{"name":"Pathology and Laboratory Medicine"},{"name":"Geisel School of Medicine at Dartmouth, Hanover, NH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lester D.R.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Department of Pathology, Southern California Permanente Medical Group, Woodland Hills, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Tafe","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine"},{"name":"Geisel School of Medicine at Dartmouth, Hanover, NH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vickie Y.","family":"Jo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital and Harvard Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azfar","family":"Neyaz","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashanthi","family":"Divakar","sequence":"additional","affiliation":[{"name":"Section of Otolaryngology, Dartmouth-Hitchcock Medical Center, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Paydarfar","sequence":"additional","affiliation":[{"name":"Section of Otolaryngology, Dartmouth-Hitchcock Medical Center, Lebanon"},{"name":"Geisel School of Medicine at Dartmouth, Hanover, NH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Pastel","sequence":"additional","affiliation":[{"name":"Radiology"},{"name":"Geisel School of Medicine at Dartmouth, Hanover, NH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Shirai","sequence":"additional","affiliation":[{"name":"Medical Oncology"},{"name":"Geisel School of Medicine at Dartmouth, Hanover, NH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivy","family":"John","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Pittsburgh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja R.","family":"Seethala","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Pittsburgh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia M.","family":"Salgado","sequence":"additional","affiliation":[{"name":"Department of Pathology, Children\u2019s Hospital of Pittsburgh, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Deshpande","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia A.","family":"Bridge","sequence":"additional","affiliation":[{"name":"Molecular Division, ProPath LLC, Dallas, TX"},{"name":"Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Kashofer","sequence":"additional","affiliation":[{"name":"Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iva","family":"Br\u010di\u0107","sequence":"additional","affiliation":[{"name":"Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Linos","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine"},{"name":"Geisel School of Medicine at Dartmouth, Hanover, NH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,5,18]]},"reference":[{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1158\/2159-8290.CD-14-0377","article-title":"Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions","volume":"4","author":"Lovly","year":"2014","journal-title":"Cancer Discov"},{"key":"R3-20250608","first-page":"1604","article-title":"Inflammatory myofibroblastic tumors of the head and nec","volume":"8","author":"Tao","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00000478-199508000-00001","article-title":"Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases","volume":"19","author":"Coffin","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/PAS.0b013e318200cfd5","article-title":"Epithelioid inflammatory myofibroblastic sarcoma: an aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK","volume":"35","author":"Mari\u00f1o-Enr\u00edquez","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/jcp.2007.049387","article-title":"Inflammatory myofibroblastic tumours: where are we now?","volume":"61","author":"Gleason","year":"2008","journal-title":"J Clin Pathol"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/01.pas.0000213393.57322.c7","article-title":"Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases","volume":"31","author":"Coffin","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/PAS.0000000000000404","article-title":"Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement","volume":"39","author":"Antonescu","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"e28220","DOI":"10.1002\/pbc.28220","article-title":"Gene rearrangements in consecutive series of pediatric inflammatory myofibroblastic tumors","volume":"67","author":"Preobrazhenskaya","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1097\/00000478-200111000-00003","article-title":"Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study","volume":"25","author":"Cook","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/01.MP.0000026615.04130.1F","article-title":"Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases","volume":"15","author":"Cessna","year":"2002","journal-title":"Mod Pathol"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/his.12910","article-title":"ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours","volume":"69","author":"Yamamoto","year":"2016","journal-title":"Histopathology"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/his.13839","article-title":"Gene fusion involving the insulin-like growth factor 1 receptor in an ALK-negative inflammatory myofibroblastic tumour","volume":"74","author":"Piarulli","year":"2019","journal-title":"Histopathology"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1056\/NEJMoa1007056","article-title":"Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor","volume":"363","author":"Butrynski","year":"2010","journal-title":"N Engl J Med"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/modpathol.2017.69","article-title":"Inflammatory myofibroblastic tumor of the uterus: a clinicopathological, immunohistochemical, and molecular analysis of 13 cases highlighting their broad morphologic spectrum","volume":"30","author":"Bennett","year":"2017","journal-title":"Mod Pathol"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/PAS.0000000000001167","article-title":"Morphologic overlap between inflammatory myofibroblastic tumor and IgG4-related disease: lessons from next-generation sequencing","volume":"43","author":"Taylor","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/his.13649","article-title":"Spindle cell rhabdomyosarcoma of bone with FUS-TFCP2 fusion: confirmation of a very recently described rhabdomyosarcoma subtype","volume":"73","author":"Dashti","year":"2018","journal-title":"Histopathology"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/path.5053","article-title":"Transcriptomic definition of molecular subgroups of small round cell sarcomas","volume":"245","author":"Watson","year":"2018","journal-title":"J Pathol"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/CCO.0b013e328354c155","article-title":"Anaplastic lymphoma kinase-directed therapy in inflammatory myofibroblastic tumors","volume":"24","author":"Tothova","year":"2012","journal-title":"Curr Opin Oncol"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1158\/1078-0432.CCR-11-0063","article-title":"Pulmonary inflammatory myofibroblastic tumor expressing a novel fusion, PPFIBP1-ALK: reappraisal of anti-ALK immunohistochemistry as a tool for novel ALK fusion identification","volume":"17","author":"Takeuchi","year":"2011","journal-title":"Clin Cancer Res"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/modpathol.2014.165","article-title":"Expression of ROS1 predicts ROS1 gene rearrangement in inflammatory myofibroblastic tumors","volume":"28","author":"Hornick","year":"2015","journal-title":"Mod Pathol"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/pin.12796","article-title":"Vocal cord inflammatory myofibroblastic tumor with mucoid deposits harboring TIMP3-ALK fusion: a potential diagnostic pitfall","volume":"69","author":"Yorita","year":"2019","journal-title":"Pathol Int"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.humpath.2019.12.006","article-title":"Uterine inflammatory myofibroblastic tumors in pregnant women with and without involvement of the placenta: a study of 6 cases with identification of a novel TIMP3-RET fusion","volume":"97","author":"Cheek","year":"2020","journal-title":"Hum Pathol"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.humpath.2020.09.005","article-title":"Inflammatory myofibroblastic tumors associated with the placenta: a series of 9 cases","volume":"106","author":"Makhdoum","year":"2020","journal-title":"Hum Pathol"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/PAS.0000000000001481","article-title":"Pregnancy-associated inflammatory myofibroblastic tumors of the uterus are clinically distinct and highly enriched for TIMP3-ALK and THBS1-ALK fusions","volume":"44","author":"Devereaux","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1440-1827.2006.02012.x","article-title":"Absence of human herpesvirus-8 and Epstein-Barr virus in inflammatory myofibroblastic tumor with anaplastic large cell lymphoma kinase fusion gene","volume":"56","author":"Yamamoto","year":"2006","journal-title":"Pathol Int"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0002-9440(10)64550-6","article-title":"TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors","volume":"157","author":"Lawrence","year":"2000","journal-title":"Am J Pathol"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"bcr2018226431","DOI":"10.1136\/bcr-2018-226431","article-title":"A novel KIF5B-ALK fusion in a child with an atypical central nervous system inflammatory myofibroblastic tumour","volume":"2018","author":"Maruggi","year":"2018","journal-title":"BMJ Case Rep"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1158\/1078-0432.CCR-08-3248","article-title":"KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer","volume":"15","author":"Takeuchi","year":"2009","journal-title":"Clin Cancer Res"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/1759-7714.12613","article-title":"ALK-rearrangement in non-small-cell lung cancer (NSCLC)","volume":"9","author":"Du","year":"2018","journal-title":"Thorac Cancer"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41379-018-0168-6","article-title":"ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion","volume":"32","author":"Chang","year":"2019","journal-title":"Mod Pathol"},{"key":"R33-20250608","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/PAS.0000000000001567","article-title":"ALK-positive histiocytosis of the breast: a clinicopathologic study highlighting spindle cell histology","volume":"45","author":"Kashima","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R34-20250608","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1097\/01.LAB.0000088856.49388.EA","article-title":"Identification of CARS-ALK fusion in primary and metastatic lesions of an inflammatory myofibroblastic tumor","volume":"83","author":"Debelenko","year":"2003","journal-title":"Lab Invest"},{"key":"R35-20250608","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/gcc.10033","article-title":"Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor","volume":"34","author":"Cools","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"R36-20250608","doi-asserted-by":"crossref","DOI":"10.1002\/onco.13745","article-title":"Novel SLC12A2-ROS1 fusion in non-small cell lung cancer with a significant response to crizotinib: the importance of choosing the appropriate next-generation sequencing assay","author":"Rodr\u00edguez-Antol\u00edn","year":"2021","journal-title":"Oncologist"},{"key":"R37-20250608","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1056\/NEJMoa1406766","article-title":"Crizotinib in ROS1-rearranged non-small-cell lung cancer","volume":"371","author":"Shaw","year":"2014","journal-title":"N Engl J Med"},{"key":"R38-20250608","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.1158\/1078-0432.CCR-12-0550","article-title":"Identifying and targeting ROS1 gene fusions in non-small cell lung cancer","volume":"18","author":"Davies","year":"2012","journal-title":"Clin Cancer Res"},{"key":"R39-20250608","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1158\/1078-0432.CCR-12-2851","article-title":"Molecular pathways: ROS1 fusion proteins in cancer","volume":"19","author":"Davies","year":"2013","journal-title":"Clin Cancer Res"},{"key":"R40-20250608","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nm.2658","article-title":"RET, ROS1 and ALK fusions in lung cancer","volume":"18","author":"Takeuchi","year":"2012","journal-title":"Nat Med"},{"key":"R41-20250608","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s12105-020-01273-6","article-title":"The most common mistake in laryngeal pathology and how to avoid it","volume":"15","author":"Heidarian","year":"2021","journal-title":"Head Neck Pathol"},{"key":"R42-20250608","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41379-019-0323-8","article-title":"A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation","volume":"33","author":"Le Loarer","year":"2020","journal-title":"Mod Pathol"},{"key":"R43-20250608","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature15258","article-title":"Alternative transcription initiation leads to expression of a novel ALK isoform in cancer","volume":"526","author":"Wiesner","year":"2015","journal-title":"Nature"},{"key":"R44-20250608","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1007\/s12105-020-01171-x","article-title":"Well-differentiated\/dedifferentiated liposarcoma arising in the upper aerodigestive tract: 8 cases mimicking non-adipocytic lesions","volume":"14","author":"Fritchie","year":"2020","journal-title":"Head Neck Pathol"},{"key":"R45-20250608","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.5858\/arpa.2018-0205-RA","article-title":"Dedifferentiated liposarcoma with myofibroblastic differentiation","volume":"142","author":"Wang","year":"2018","journal-title":"arch Pathol Lab Med"},{"key":"R46-20250608","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41379-020-00703-8","article-title":"\u2018Inflammatory leiomyosarcoma\u2019 and \u2018histiocyte-rich rhabdomyoblastic tumor\u2019: a clinicopathological, immunohistochemical and genetic study of 13 cases, with a proposal for reclassification as \u2018Inflammatory Rhabdomyoblastic Tumor\u2019","volume":"34","author":"Cloutier","year":"2021","journal-title":"Mod Pathol"},{"key":"R47-20250608","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00428-020-02774-z","article-title":"Inflammatory leiomyosarcoma shows frequent co-expression of smooth and skeletal muscle markers supporting a primitive myogenic phenotype: a report of 9 cases with a proposal for reclassification as low-grade inflammatory myogenic tumor","volume":"477","author":"Michal","year":"2020","journal-title":"Virchows Arch"},{"key":"R48-20250608","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/00000478-200109000-00005","article-title":"Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics","volume":"25","author":"Cessna","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R49-20250608","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/modpathol.2017.113","article-title":"Inflammatory leiomyosarcoma is a distinct tumor characterized by near-haploidization, few somatic mutations, and a primitive myogenic gene expression signature","volume":"31","author":"Arbajian","year":"2018","journal-title":"Mod Pathol"},{"key":"R50-20250608","doi-asserted-by":"crossref","first-page":"E65","DOI":"10.1002\/dc.24584","article-title":"Fine needle aspiration of an intranodal follicular dendritic cell sarcoma: a case report with molecular analysis and review of the literature","volume":"49","author":"Andersen","year":"2021","journal-title":"Diagn Cytopathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001735","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T17:06:44Z","timestamp":1749402404000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001735"}},"subtitle":["Highlighting a Novel Fusion and Potential Diagnostic Pitfall"],"short-title":[],"issued":{"date-parts":[[2021,5,18]]},"references-count":49,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001735","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,18]]}}}